Coding Bio

Coding Bio is a biotechnology company that is engineering modular immunotherapies for cancer by combining high-throughput cellular screening with machine learning. The company screens millions of protein candidates in living cells to identify the best designs for inducing an immune response. This enables the development of best-in-class immunotherapies in months rather than years. Based in Oxford, United Kingdom, Coding Bio was founded in 2020 by a team of experts in immuno-oncology, cell therapy, and machine learning.